New diabetes combo pill passes first safety check in healthy volunteers
NCT ID NCT07548957
First seen Apr 23, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This early-stage study tests a new experimental drug, UI087, against taking three separate diabetes medicines together. It involves 44 healthy adults who will receive a single dose of each treatment on different days to compare safety and how the drug moves through the body. The goal is to see if UI087 can be a simpler, single-pill option for managing Type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H plus Yangji Hospital
Seoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.